{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T14:07:03Z","timestamp":1772114823745,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"National R&D Program for Cancer Control of the National Cancer Cente","award":["HA22C0021"],"award-info":[{"award-number":["HA22C0021"]}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1136\/ijgc-2022-004200","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T10:36:07Z","timestamp":1684751767000},"page":"1106-1111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Radiotherapy in recurrent ovarian cancer: updated results of involved-field radiation therapy"],"prefix":"10.1016","volume":"33","clinical-trial-number":[{"clinical-trial-number":"nct05444270","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5970-9773","authenticated-orcid":false,"given":"Byung Min","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9858-6251","authenticated-orcid":false,"given":"Seo Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4742-2772","authenticated-orcid":false,"given":"Nalee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8964-6275","authenticated-orcid":false,"given":"Hwa Kyung","family":"Byun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7573-6862","authenticated-orcid":false,"given":"Yong Bae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2022-004200_bb0010","author":"National Cancer Centre","year":"2023","journal-title":"Korean National cancer Statistics"},{"key":"10.1136\/ijgc-2022-004200_bb0015","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/jamaoncol.2018.2761","article-title":"Defining survivorship trajectories across patients with solid tumors: an evidence-based approach","volume":"4","author":"Dood","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1136\/ijgc-2022-004200_bb0020","doi-asserted-by":"crossref","DOI":"10.6004\/jnccn.2022.0047","article-title":"Ovarian cancer, version 4.2022, NCCN Clinical Practice Guidelines in Oncology","author":"Armstrong","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1136\/ijgc-2022-004200_bb0025","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ijrobp.2018.03.058","article-title":"Stereotactic body radiation therapy for Oligometastatic ovarian cancer: A step toward a drug holiday","volume":"101","author":"Lazzari","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2022-004200_bb0030","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ygyno.2004.11.008","article-title":"Impact of tumor volume-directed involved field radiation therapy integrated in the management of recurrent ovarian cancer","volume":"96","author":"Albuquerque","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2022-004200_bb0035","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/IGC.0000000000000653","article-title":"Long-term benefit of tumor volume-directed involved field radiation therapy in the management of recurrent ovarian cancer","volume":"26","author":"Albuquerque","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004200_bb0040","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0360-3016(01)01733-3","article-title":"Effective palliative radiation therapy in advanced and recurrent ovarian carcinoma","volume":"51","author":"Tinger","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2022-004200_bb0045","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ygyno.2013.04.469","article-title":"Involved-field radiation therapy for Locoregionally recurrent ovarian cancer","volume":"130","author":"Brown","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2022-004200_bb0050","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2019.30.e67","article-title":"Involved-field radiation therapy for selected cases of recurrent ovarian cancer","volume":"30","author":"Kim","year":"2019","journal-title":"J Gynecol Oncol"},{"key":"10.1136\/ijgc-2022-004200_bb0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ygyno.2018.08.012","article-title":"Involved-field radiation therapy for recurrent ovarian cancer: results of a multi-institutional prospective phase II trial","volume":"151","author":"Chang","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2022-004200_bb0060","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijrobp.2021.09.027","article-title":"A story of hypofractionation and the table on the wall","volume":"112","author":"Timmerman","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2022-004200_bb0065","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/pan\/mpl013","article-title":"Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference","volume":"15","author":"Ho","year":"2007","journal-title":"Political Analysis"},{"key":"10.1136\/ijgc-2022-004200_bb0070","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0002-9378(79)90950-5","article-title":"Ovarian carcinoma: improved survival following abdominopelvic irradiation in patients with a completed pelvic operation","volume":"134","author":"Dembo","year":"1979","journal-title":"Am J Obstet Gynecol"},{"key":"10.1136\/ijgc-2022-004200_bb0075","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0360-3016(92)90777-F","article-title":"Epithelial ovarian cancer: the role of radiotherapy","volume":"22","author":"Dembo","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2022-004200_bb0080","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1525-1438.1993.03010024.x","article-title":"Testing the validity of a prognostic classification in patients with surgically optimal ovarian carcinoma: a 15-year review","volume":"3","author":"Carey","year":"1993","journal-title":"Int J Gynecol Cancer"},{"issue":"4 Suppl","key":"10.1136\/ijgc-2022-004200_bb0085","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/cncr.2820710441","article-title":"Integrating radiation therapy into the management of ovarian-cancer","volume":"71","author":"Thomas","year":"1993","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2022-004200_bb0090","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00000421-199402000-00016","article-title":"High-risk early-stage ovarian cancer. randomized clinical trial comparing cisplatin plus cyclophosphamide versus whole abdominal radiotherapy","volume":"17","author":"Chiara","year":"1994","journal-title":"Am J Clin Oncol"},{"key":"10.1136\/ijgc-2022-004200_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0936-6555(05)80682-X","article-title":"The West Midlands epithelial ovarian cancer adjuvant therapy trial","volume":"5","author":"Redman","year":"1993","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1136\/ijgc-2022-004200_bb0100","first-page":"149","article-title":"Postoperative treatment of early cancer of the ovary: a random trial between postoperative irradiation and chemotherapy","volume":"42","author":"Smith","year":"1975","journal-title":"Natl Cancer Inst Monogr"},{"key":"10.1136\/ijgc-2022-004200_bb0105","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/igc.0000000000001139","article-title":"Palliative radiation therapy for recurrent ovarian cancer: efficacy and predictors of clinical response","volume":"28","author":"Jiang","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-004200_bb0110","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1006\/gyno.1998.4934","article-title":"Palliative benefit of external-beam radiation in the management of platinum refractory epithelial ovarian carcinoma","volume":"69","author":"Gelblum","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2022-004200_bb0115","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1002\/1097-0142(19941201)74:11<2979::AID-CNCR2820741114>3.0.CO;2-B","article-title":"Recurrent ovarian cancer. Effective radiotherapeutic palliation after chemotherapy failure","volume":"74","author":"Corn","year":"1994","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2022-004200_bb0120","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3857\/roj.2017.00213","article-title":"Radiation for persistent or recurrent epithelial ovarian cancer: a need for reassessment","volume":"35","author":"Choi","year":"2017","journal-title":"Radiat Oncol J"},{"key":"10.1136\/ijgc-2022-004200_bb0125","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1006\/gyno.1993.1302","article-title":"Limited-field radiotherapy as salvage treatment of localized persistent or recurrent epithelial ovarian cancer","volume":"51","author":"Davidson","year":"1993","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2022-004200_bb0130","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrc2583","article-title":"Beyond chemotherapy: targeted therapies in ovarian cancer","volume":"9","author":"Yap","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1136\/ijgc-2022-004200_bb0135","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-018-4498-z","article-title":"Changes in ovarian cancer survival during the 20 years before the era of targeted therapy","volume":"18","author":"Lee","year":"2018","journal-title":"BMC Cancer"},{"issue":"suppl_8","key":"10.1136\/ijgc-2022-004200_bb0140","doi-asserted-by":"crossref","first-page":"viii1","DOI":"10.1093\/annonc\/mdx444","article-title":"Immunotherapy in ovarian cancer","volume":"28","author":"Odunsi","year":"2017","journal-title":"Ann Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24016165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24016165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2022-004200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:28:42Z","timestamp":1753234122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24016165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1048891X24016165"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2022-004200","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiotherapy in recurrent ovarian cancer: updated results of involved-field radiation therapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2022-004200","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}